LIVE QUOTE
The Cooper Companies, Inc. COO
Healthcare · Medical - Instruments & Supplies · NASDAQ
$69.31
Market Cap$18.0B
P/E Ratio22.0
Beta1.03
Employees16,000

Investment Thesis

.

Competitive Moat

COO enjoys a strong competitive moat characterized by intangible assets, specifically its brand reputation and regulatory compliance in the healthcare sector. The company's established presence in the contact lens market creates significant switching costs for consumers, as well as healthcare providers who rely on its innovative products. This competitive advantage is expected to remain durable over the next 5-10 years, although competitive threats from emerging players and technological advancements in vision correction could pose challenges to its market share.

Growth Engine

Future revenue growth for COO will primarily stem from its CooperVision segment, which capitalizes on a global total addressable market (TAM) projected to grow due to increasing eye health awareness and an aging population. The company is poised to expand its geographic footprint, particularly in Asia-Pacific, while also introducing new product lines that cater to evolving consumer needs. Organic growth is supported by a solid pipeline of innovative products, while recent acquisitions have bolstered its capabilities in the women's health space, indicating a balanced approach to growth.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Morningstar Investor
Analyst ratings, fair value, moat
Research COO
Robinhood
$0 commission trades
Trade COO
Webull
Extended-hours, options, charts
Trade COO
TradingView
Advanced charts & screeners
Chart COO
We may earn a commission if you open an account through our links, at no extra cost to you.
Loading chart...

Frequently Asked Questions

As of 2026-04-13, COO's P/E ratio is not available, which may indicate that the company is not currently profitable or is in a growth phase. Without a market cap provided, it is difficult to assess its valuation relative to other companies in the healthcare sector.
The Cooper Companies, Inc. does not currently pay a dividend.
COO operates in the healthcare sector, specifically within the medical instruments and supplies industry.
The market capitalization for The Cooper Companies, Inc. is not available, making it challenging to classify its size within the market.
Competitors of The Cooper Companies, Inc. include companies such as Johnson & Johnson and Bausch + Lomb, which also operate in the medical instruments and supplies industry.
FAQ generated 2026-04-13

Related Reading

Related Stocks

← View in Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms